October 28, 2021 – Structure-Based Drug Design of ALK inhibitors in pre-clinical models

Further studies including the cloning and sequencing of the of zinc-metalloprotease genes from WS pathogens will enable validation of our current findings, potentially by utilizing mutant coral pathogen strains that lack the zinc-metalloprotease gene, or by utilizing differential expression and coral pathogen zinc-metalloproteases expressed by a vector system in additional exposure trials [82] aimed at fulfilling Koch’s molecular postulates [83]

By moca09Posted on October 28, 2021Posted in Cholecystokinin2 Receptors

Further studies including the cloning and sequencing of the of zinc-metalloprotease genes from WS pathogens will enable validation of our current findings, potentially by utilizing mutant coral pathogen strains that lack the zinc-metalloprotease gene, or by utilizing differential expression and coral pathogen zinc-metalloproteases expressed by a vector system in additional exposure trials [82] aimed at […]